Literature DB >> 15655257

Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotection.

Illana Gozes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15655257     DOI: 10.1385/JMN:24:3:333

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


× No keyword cloud information.
  30 in total

1.  EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials.

Authors:  Vered Lavie; Maria Becker; Rachel Cohen-Kupiec; Iftach Yacoby; Rela Koppel; Manuela Wedenig; Birgit Hutter-Paier; Beka Solomon
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 2.  Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging.

Authors:  Mei-Ping Kung; Zhi-Ping Zhuang; Cathy Hou; Hank F Kung
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

3.  Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

Authors:  D Offen; Y Sherki; E Melamed; M Fridkin; D E Brenneman; I Gozes
Journal:  Brain Res       Date:  2000-01-31       Impact factor: 3.252

4.  Cloning and characterization of the human activity-dependent neuroprotective protein.

Authors:  R Zamostiano; A Pinhasov; E Gelber; R A Steingart; E Seroussi; E Giladi; M Bassan; Y Wollman; H J Eyre; J C Mulley; D E Brenneman; I Gozes
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

Review 5.  ADAMs family members as amyloid precursor protein alpha-secretases.

Authors:  Tobias M J Allinson; Edward T Parkin; Anthony J Turner; Nigel M Hooper
Journal:  J Neurosci Res       Date:  2003-11-01       Impact factor: 4.164

Review 6.  MAPREG: toward a novel approach of neuroprotection and treatment of Alzheimer's disease.

Authors:  Etienne-Emile Baulieu; Paul Robel; Arlette Fellous; Yann Duchossoy; Virginie Fontaine-Lenoir; Sebastien David
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain.

Authors:  D Larry Sparks
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  NAP mechanisms of neuroprotection.

Authors:  Illana Gozes; Ruth A Steingart; Avron D Spier
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze.

Authors:  Roy N Alcalay; Eliezer Giladi; Chaim G Pick; Illana Gozes
Journal:  Neurosci Lett       Date:  2004-05-06       Impact factor: 3.046

Review 10.  From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.

Authors:  Illana Gozes; Inna Divinsky; Inbar Pilzer; Mati Fridkin; Douglas E Brenneman; Avron D Spier
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

View more
  2 in total

1.  Establishment of stably transfected rat neuronal cell lines expressing alpha-synuclein GFP fusion proteins.

Authors:  Gert Schwach; Michaela Tschemmernegg; Roswitha Pfragner; Elisabeth Ingolic; Edith Schreiner; Manfred Windisch
Journal:  J Mol Neurosci       Date:  2009-10-09       Impact factor: 3.444

2.  Alterations of Nigral Dopamine Levels in Parkinson's Disease after Environmental Enrichment and PACAP Treatment in Aging Rats.

Authors:  Adel Jungling; Dora Reglodi; Gabor Maasz; Zita Zrinyi; Janos Schmidt; Adam Rivnyak; Gabor Horvath; Zsolt Pirger; Andrea Tamas
Journal:  Life (Basel)       Date:  2021-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.